Home > PS Ratio > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
PS (Price/Sales) Ratio

The Current P/S Ratio of STRIDES PHARMA SCIENCE is 1.73.

Share Price ₹878.7Dec 05,2025
Market Cap ₹8,101.2 Cr
Sales-TTM₹4,684.6 CrTTM-Consolidated Results
Price/Sales1.73xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of STRIDES PHARMA SCIENCE

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of STRIDES PHARMA SCIENCE is calculated as :

Current Market Cap [ ₹8,101.2 Cr] as on Dec 05,2025

(/) Sales [ ₹4,684.6 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.73x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for STRIDES PHARMA SCIENCE , the investors are currently willing to pay '1.73 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of STRIDES PHARMA SCIENCE !

The chart below summarizes the trend in P/S Ratio of STRIDES PHARMA SCIENCE over the last five years.

Historical PS (Price/Sales) ratio chart of STRIDES PHARMA SCIENCE


PS Ratio Performance Analysis for STRIDES PHARMA SCIENCE

- STRIDES PHARMA SCIENCE 's latest p/e ratio is 1.73x.

- STRIDES PHARMA SCIENCE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.44x.

- STRIDES PHARMA SCIENCE 's operated at median p/e ratio of 1.35x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, STRIDES PHARMA SCIENCE 's p/e ratio peaked in Mar2021 at 2.28x.

- STRIDES PHARMA SCIENCE 's p/e ratio hit its five-year low in Mar2023 of 0.7x.


How does STRIDES PHARMA SCIENCE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
STRIDES PHARMA SCIENCE 4,684.61.738,101.2
SUN PHARMACEUTICAL INDUSTRIES LTD54,964.07.88433,068.0
DIVIS LABORATORIES LTD10,029.017.14171,847.0
CIPLA LTD28,349.64.33122,826.0
TORRENT PHARMACEUTICALS LTD12,248.010.45127,985.0
DR REDDYS LABORATORIES LTD34,310.03.10106,418.0
MANKIND PHARMA LTD13,576.96.7091,011.1
ZYDUS LIFESCIENCES LTD24,493.93.8393,725.7
LUPIN LTD24,750.73.8795,812.7
AUROBINDO PHARMA LTD32,514.52.1770,709.7
ABBOTT INDIA LTD6,714.49.1461,345.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs STRIDES PHARMA SCIENCE 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.73x
Max industry PS 17.14x
Median industry PS 4.33x
Average industry PS 6.39x



You may also like the below Video Courses